AllianceBernstein
TXG icon

AllianceBernstein’s 10x Genomics TXG Stock Holding History

AllianceBernstein’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.04M Sell
125,131
-1,069
-0.8% -$21.4K ﹤0.01% 1996
2025
Q4 		$2.06M Hold
126,200
– – ﹤0.01% 1987
2025
Q3 		$1.48M Sell
126,200
-307
-0.2% -$4K ﹤0.01% 2162
2025
Q2 		$1.46M Buy
126,507
+90,988
+256% +$829K ﹤0.01% 2085
2025
Q1 		$310K Buy
35,519
+24
+0.1% +$303 ﹤0.01% 2756
2024
Q4 		$510K Sell
35,495
-353
-1% -$5.57K ﹤0.01% 2634
2024
Q3 		$809K Sell
35,848
-6,670
-16% -$138K ﹤0.01% 2420
2024
Q2 		$827K Buy
42,518
+11,224
+36% +$294K ﹤0.01% 2404
2024
Q1 		$1.17M Buy
31,294
+660
+2% +$29K ﹤0.01% 2174
2023
Q4 		$1.71M Buy
30,634
+1,248
+4% +$54.3K ﹤0.01% 2022
2023
Q3 		$1.21M Sell
29,386
-888
-3% -$46.2K ﹤0.01% 2141
2023
Q2 		$1.69M Sell
30,274
-320
-1% -$17.3K ﹤0.01% 1996
2023
Q1 		$1.71M Sell
30,594
-6,325
-17% -$295K ﹤0.01% 1961
2022
Q4 		$1.35M Buy
36,919
+130
+0.4% +$4.25K ﹤0.01% 2133
2022
Q3 		$1.05M Buy
36,789
+69
+0.2% +$2.63K ﹤0.01% 2262
2022
Q2 		$1.66M Buy
36,720
+664
+2% +$34.4K ﹤0.01% 2059
2022
Q1 		$2.74M Sell
36,056
-780,682
-96% -$68.3M ﹤0.01% 1908
2021
Q4 		$122M Buy
816,738
+73,255
+10% +$11.2M 0.04% 381
2021
Q3 		$108M Buy
743,483
+89,390
+14% +$15.3M 0.04% 401
2021
Q2 		$128M Buy
654,093
+22,112
+3% +$4M 0.05% 349
2021
Q1 		$114M Sell
631,981
-150,344
-19% -$26M 0.05% 373
2020
Q4 		$111M Sell
782,325
-448,131
-36% -$65M 0.05% 347
2020
Q3 		$153M Sell
1,230,456
-301,794
-20% -$31.7M 0.08% 221
2020
Q2 		$137M Sell
1,532,250
-40,760
-3% -$3.17M 0.08% 226
2020
Q1 		$98M Buy
1,573,010
+594,693
+61% +$46.4M 0.07% 261
2019
Q4 		$74.6M Buy
978,317
+679,482
+227% +$40.9M 0.04% 418
2019
Q3 		$15.1M Buy
+298,835
New +$16.5M 0.01% 894

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein's TXG Position: Q1 2026 in Review

AllianceBernstein reduced its 10x Genomics (TXG) stake by 0.85% in Q1 2026, selling an estimated $21.4K and leaving 125,131 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

AllianceBernstein first reported a position in TXG in Q3 2019 and has held it in 27 quarters since. The position peaked at $153M in Q3 2020. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • AllianceBernstein held 125,131 shares of 10x Genomics worth $2.04M as of Q1 2026.
  • AllianceBernstein sold 1,069 10x Genomics shares in Q1 2026, an estimated $21.4K.
  • 10x Genomics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1996 holding.
  • AllianceBernstein first reported a position in 10x Genomics in Q3 2019 and has held it in 27 quarters since.
  • AllianceBernstein's 10x Genomics position peaked at $153M in Q3 2020.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.